cysteine has been researched along with Coronary Disease in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (13.64) | 18.7374 |
| 1990's | 8 (36.36) | 18.2507 |
| 2000's | 11 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuchs, D; Mark, M; Reinhart, WH; Schroecksnadel, K; Walter, RB; Weiss, G | 1 |
| Chiang, AN; Chiang, SC; Chou, SC; Lai, ST; Pan, JP | 1 |
| Heng, CK; Low, PS; Saha, N; Tan, JH; Tan, YS; Tong, MC; Yang, H | 1 |
| Breitkreutz, R; Cafaltzis, K; Deigner, HP; Dröge, W; Edler, L; Feussner, G; Hildebrandt, W; Kinscherf, R; Kreuzer, J; Metz, J; Michel, G; Röder, F; Werle, E | 1 |
| Emery, PW; Johnston, K; Obeid, OA | 1 |
| Obeid, OA | 1 |
| Boran, G; Enright, H; Fitzgerald, A; Fogarty, J; Gaffney, P; Graham, IM; Hanbidge, M; McCarthy, B; Murphy, J; O'Callaghan, PA | 1 |
| Cui, RZ; Li, Y; Li, YL; Qin, Q; Wang, H; Zhao, BR; Zhao, FM | 1 |
| Allen, SP; Yacoub, MH | 1 |
| Assmann, G; Beucler, I; Bruckert, E; Funke, H; Turpin, G; von Eckardstein, A; Wiebusch, H | 1 |
| Boileau, C; Erlich, D; Giraudet, P; Jondeau, G; Junien, C; Krempf, M; Rabès, JP; Saint-Jore, B; Varret, M | 1 |
| Bjerve, KS; Carlsen, SM; Følling, I; Grill, V; Refsum, H; Schneede, J | 1 |
| Donner, MG; Klein, GK; Mathes, PB; Richter, WO; Schwandt, P | 1 |
| Frei, B; Gokce, N; Holbrook, M; Keaney, JF; Leaf, C; Vita, JA | 1 |
| Fessler, RD; Guterman, LR; Hopkins, LN; Lanzino, G; Lopes, DK; Miletich, RS | 1 |
| Banerjee, S; Das, T; Pillai, MR; Ramamoorthy, N; Samuel, G; Sarma, HD | 1 |
| Banerjee, S; Chakraborty, S; Das, T; Pillai, MR; Ramamoorthy, N; Samuel, G; Sarma, HD; Unni, PR | 1 |
| Ozkan, E; Ozkan, Y; Simşek, B | 1 |
| Carey, C; Lefer, AM; Ma, XL; Siegfried, MR | 1 |
| Cargnoni, A; Ceconi, C; Condorelli, E; Curello, S; Ferrari, R; Raddino, R | 1 |
| Mehrishi, JN | 1 |
| Gerhold, WM; Mandel, EE | 1 |
1 review(s) available for cysteine and Coronary Disease
| Article | Year |
|---|---|
Role of leukotrienes in coronary artery surgery.
Topics: Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Cysteine; Humans; Inflammation; Inflammation Mediators; Leukotrienes; Myocardial Ischemia; Vasoconstrictor Agents | 1995 |
2 trial(s) available for cysteine and Coronary Disease
| Article | Year |
|---|---|
Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease.
Topics: Adult; Coronary Disease; Cysteine; Folic Acid; Homocysteine; Humans; Hypoglycemic Agents; Male; Metformin; Methylmalonic Acid; Middle Aged; Vitamin B 12 | 1997 |
L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease.
Topics: Administration, Oral; Aged; Arteriosclerosis; Blood Flow Velocity; Blood Glucose; Blood Pressure; Cholesterol; Coronary Disease; Cysteine; Double-Blind Method; Endothelium, Vascular; Female; Glutathione; Heart Rate; Humans; Hyperemia; Male; Middle Aged; Nitric Oxide; Nitroglycerin; Oxidation-Reduction; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines; Triglycerides; Ultrasonography | 1998 |
19 other study(ies) available for cysteine and Coronary Disease
| Article | Year |
|---|---|
Association between plasma thiols and immune activation marker neopterin in stable coronary heart disease.
Topics: Aged; Biomarkers; Coronary Angiography; Coronary Disease; Cysteine; Female; Homocysteine; Humans; Male; Middle Aged; Neopterin; Predictive Value of Tests; Sulfhydryl Compounds | 2008 |
The risk of coronary artery disease in population of Taiwan is associated with Cys-Ser 311 polymorphism of human paraoxonase (PON)-2 gene.
Topics: Adult; Aged; Aryldialkylphosphatase; Coronary Disease; Cysteine; Esterases; Female; Genetic Predisposition to Disease; Genotype; Humans; Lipids; Male; Middle Aged; Polymorphism, Genetic; Risk; Serine; Taiwan | 2002 |
ABCA1 gene polymorphisms and their associations with coronary artery disease and plasma lipids in males from three ethnic populations in Singapore.
Topics: Alanine; Apolipoprotein A-I; Asian People; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Cysteine; Genotype; Glycine; Haplotypes; Humans; India; Isoleucine; Linkage Disequilibrium; Lipids; Malaysia; Male; Methionine; Polymorphism, Genetic; Sequence Analysis, DNA; Singapore; Threonine; Triglycerides; Valine; White People | 2003 |
Cholesterol levels linked to abnormal plasma thiol concentrations and thiol/disulfide redox status in hyperlipidemic subjects.
Topics: Amino Acids; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Cysteine; Disulfides; Glutathione; Humans; Hyperlipidemias; Oxidation-Reduction; Sulfhydryl Compounds; Taurine; Triglycerides | 2003 |
Plasma taurine and cysteine levels following an oral methionine load: relationship with coronary heart disease.
Topics: Adult; Case-Control Studies; Coronary Disease; Cysteine; Europe; Fasting; Humans; India; Male; Methionine; Middle Aged; Pyridoxal Phosphate; Pyridoxic Acid; Taurine | 2004 |
Plasma amino acid concentrations in patients with coronary heart disease: a comparison between U.K. Indian Asian and Caucasian men.
Topics: Alanine; Asian People; Biomarkers; Blood Glucose; Coronary Disease; Cysteine; Feeding Behavior; Humans; Male; Middle Aged; White People | 2005 |
New and old cardiovascular risk factors: C-reactive protein, homocysteine, cysteine and von Willebrand factor increase risk, especially in smokers.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Coronary Disease; Cysteine; Enzyme-Linked Immunosorbent Assay; Female; Homocysteine; Humans; Incidence; Male; Middle Aged; Odds Ratio; Prognosis; Retrospective Studies; Risk Factors; Smoking; von Willebrand Factor | 2005 |
[Association of paraoxonase polymorphisms and serum homocysteine thiolactone complex with coronary heart disease].
Topics: Adult; Aged; Aryldialkylphosphatase; Coronary Disease; Cysteine; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Male; Middle Aged; Polymorphism, Genetic | 2006 |
The replacement of arginine by cysteine at residue 151 in apolipoprotein A-I produces a phenotype similar to that of apolipoprotein A-IMilano.
Topics: Adult; Aged; Apolipoprotein A-I; Arginine; Child; Cholesterol, HDL; Coronary Disease; Cysteine; Electrophoresis; Female; Heterozygote; Humans; Lipoproteins; Male; Middle Aged; Pedigree; Phenotype; Phosphatidylcholine-Sterol O-Acyltransferase; Point Mutation; Risk Factors; Sequence Analysis, DNA; Tangier Disease | 1997 |
Familial ligand-defective apolipoprotein B-100: simultaneous detection of the ARG3500-->GLN and ARG3531-->CYS mutations in a French population.
Topics: Adult; Aged; Apolipoprotein B-100; Apolipoproteins B; Arginine; Coronary Disease; Cysteine; DNA Mutational Analysis; Female; France; Genetic Testing; Genetics, Population; Glutamine; Heterozygote; Humans; Hypercholesterolemia; Male; Middle Aged; Mutagenesis, Site-Directed; Mutation; Polymerase Chain Reaction | 1997 |
Plasma total homocysteine levels in patients with early-onset coronary heart disease and a low cardiovascular risk profile.
Topics: Adult; Body Constitution; Body Mass Index; Cholesterol, HDL; Coronary Disease; Cysteine; Female; Fibrinogen; Glutathione; Homocysteine; Humans; Lipoproteins; Lipoproteins, VLDL; Male; Middle Aged; Risk Factors; Sex Characteristics; Triglycerides; Uric Acid | 1998 |
Improved cerebral perfusion after stenting of a petrous carotid stenosis: technical case report.
Topics: Aged; Angina, Unstable; Angioplasty, Balloon; Brain; Carotid Artery, Common; Carotid Stenosis; Cerebral Angiography; Cerebrovascular Circulation; Coronary Artery Bypass; Coronary Disease; Cysteine; Fibrinolytic Agents; Humans; Male; Organotechnetium Compounds; Radiopharmaceuticals; Stents; Tomography, Emission-Computed, Single-Photon; Urokinase-Type Plasminogen Activator | 1999 |
188Re-ethylene dicysteine: a novel agent for possible use in endovascular radiation therapy.
Topics: Angioplasty, Balloon, Coronary; Animals; Coronary Disease; Coronary Vessels; Cysteine; Humans; Radioisotopes; Radiopharmaceuticals; Rats; Rats, Wistar; Rhenium; Tissue Distribution | 2000 |
Potential (166)Ho radiopharmaceuticals for intravascular radiation therapy (IVRT)-I: [(166)Ho] holmium labeled ethylene dicysteine.
Topics: Animals; Chromatography, Paper; Coronary Disease; Cysteine; Holmium; Humans; Metabolic Clearance Rate; Mice; Radioisotopes; Radiopharmaceuticals; Rats; Rats, Wistar; Tissue Distribution | 2001 |
Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease.
Topics: Aged; Case-Control Studies; Coronary Disease; Cysteine; Dipeptides; Female; Folic Acid; Homocysteine; Humans; Lipoproteins, VLDL; Male; Middle Aged; Risk Factors; Triglycerides; Vitamin B 12 | 2002 |
Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion.
Topics: Animals; Cats; Coronary Disease; Cysteine; Dipeptides; Electrocardiography; Hemodynamics; Male; Myocardial Reperfusion; Myocardial Reperfusion Injury; Necrosis; Neutrophils; Nitric Oxide; Risk Factors | 1992 |
Role of oxygen in myocardial ischaemic and reperfusion damage: effect of alpha-tocopherol.
Topics: Animals; Ascorbic Acid; Catalase; Coronary Disease; Cysteine; Glutathione Peroxidase; Mitochondria, Heart; Oxygen; Rabbits; Superoxide Dismutase; Time Factors; Vitamin E | 1985 |
Smoking, cancer, and coronary heart-disease.
Topics: Blood Platelets; Carcinoma, Bronchogenic; Cell Membrane; Coronary Disease; Cysteine; Free Radicals; Humans; Lung Neoplasms; Nicotine; Radiation-Protective Agents; Smoking; Thrombosis | 1973 |
Plasma fibrin-stabilizing factor: acquired deficiency in various disorders.
Topics: Acute Disease; Adult; Aged; Anemia, Macrocytic; Anemia, Sickle Cell; Blood Coagulation Disorders; Blood Coagulation Tests; Coronary Disease; Cysteine; Factor XIII; Fibrinogen; Hepatitis; Hot Temperature; Humans; Leukemia; Liver Cirrhosis; Liver Neoplasms; Lupus Erythematosus, Systemic; Lymphoma; Methods; Middle Aged; Myeloproliferative Disorders; Neoplasm Metastasis; Prothrombin Time; Uremia | 1969 |